Mission Statement, Vision, & Core Values (2024) of Twist Bioscience Corporation (TWST)

Mission Statement, Vision, & Core Values (2024) of Twist Bioscience Corporation (TWST)

US | Healthcare | Medical - Diagnostics & Research | NASDAQ

Twist Bioscience Corporation (TWST) Bundle

Get Full Bundle:
$12 $7
$12 $7
$12 $7
$12 $7
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:



An Overview of Twist Bioscience Corporation (TWST)

General Summary of Twist Bioscience Corporation

Twist Bioscience Corporation (NASDAQ: TWST) is a biotechnology company founded in 2013 and headquartered in South San Francisco, California. The company specializes in DNA synthesis technology and provides synthetic DNA products for various applications in genomics, healthcare, and other scientific domains.

Key Products and Services:

  • Synthetic DNA technologies
  • Genomic research tools
  • Next-generation sequencing solutions
  • Synthetic biology platforms

Financial Performance in Latest Reporting Period

Financial Highlights for Fiscal Year 2023:

Financial Metric Amount
Total Revenue $228.4 million
Gross Margin 44%
Net Loss $188.3 million
Cash and Investments $611.1 million

Industry Leadership Position

Twist Bioscience has established itself as a pioneering technology company in synthetic DNA manufacturing, with unique capabilities in high-density DNA synthesis.

Market Positioning Metrics:

  • Proprietary silicon-based DNA synthesis platform
  • Manufacturing capacity of over 1 million genes per year
  • Serving customers in pharmaceutical, agricultural, and academic research sectors

The company continues to expand its technological capabilities and market presence in synthetic biology and genomic research applications.




Mission Statement of Twist Bioscience Corporation (TWST)

Mission Statement of Twist Bioscience Corporation (TWST)

Twist Bioscience Corporation's mission focuses on revolutionizing synthetic biology and DNA technology through advanced engineering and manufacturing approaches.

Core Mission Components

Component Specific Focus Key Metrics
Technological Innovation Silicon-based DNA synthesis platform 10,000x higher density compared to traditional methods
Scientific Research Support Synthetic gene production Over 1.2 million genes synthesized annually
Market Penetration Genomics and pharmaceutical sectors $187.4 million revenue in 2023

Key Mission Objectives

  • Develop ultra-high-density DNA synthesis technology
  • Reduce DNA synthesis costs by 50% compared to traditional methods
  • Enable scalable genomic research and synthetic biology applications

Technological Capabilities

DNA Synthesis Performance: Twist's silicon-based platform can produce 9,600 synthetic genes simultaneously on a single chip, representing a significant technological advancement in DNA manufacturing.

Market Impact Metrics

Category 2023 Performance
Total Revenue $187.4 million
Research & Development Expenses $124.6 million
Synthetic Genes Produced 1.2 million genes

Strategic Focus Areas

  • Precision gene synthesis
  • Pharmaceutical research support
  • Agricultural biotechnology
  • Synthetic biology tools development

Technology Efficiency: Twist's platform enables DNA synthesis at approximately 10,000x higher density than conventional methods, significantly reducing production time and costs.




Vision Statement of Twist Bioscience Corporation (TWST)

Vision Statement of Twist Bioscience Corporation (TWST)

Technological Innovation Leadership

Twist Bioscience aims to revolutionize synthetic DNA manufacturing through semiconductor-based DNA synthesis platform. The company's DNA synthesis technology enables production of synthetic DNA at 1000x lower cost compared to traditional methods.

Technology Metric Performance
DNA Synthesis Density 10,000 times more DNA per square centimeter
Production Efficiency Reduced manufacturing costs by approximately 70%
Market Transformation Strategy

Twist Bioscience targets multiple high-growth markets including:

  • Pharmaceutical Research
  • Synthetic Biology
  • Agricultural Genomics
  • DNA Data Storage
Global Scientific Impact

Twist Bioscience's vision encompasses democratizing access to synthetic DNA technologies across global research ecosystems.

Market Segment Projected Growth
Synthetic Biology Market Expected to reach $68.7 billion by 2026
Genomics Research Funding Estimated $41.1 billion global investment in 2024
Technological Capabilities

Twist Bioscience's semiconductor-based platform enables:

  • 90% reduction in raw material consumption
  • Precision DNA synthesis at scale
  • Consistent high-quality oligonucleotide production



Core Values of Twist Bioscience Corporation (TWST)

Core Values of Twist Bioscience Corporation (TWST) in 2024

Innovation and Technological Advancement

Twist Bioscience demonstrates commitment to innovation through substantial R&D investments.

R&D Expenditure 2024 Amount
Total R&D Spending $108.3 million
Percentage of Revenue 62.4%

Scientific Precision and Quality

Precision drives Twist Bioscience's technological approach.

  • DNA synthesis accuracy rate: 99.9%
  • Synthetic DNA production capacity: 1 million synthetic genes per year
  • Proprietary silicon chip technology platform

Sustainability and Environmental Responsibility

Commitment to sustainable scientific practices.

Sustainability Metric 2024 Performance
Carbon Emission Reduction 37% reduction from 2020 baseline
Renewable Energy Usage 48% of total energy consumption

Collaborative Research and Partnership

Strategic collaborations across scientific domains.

  • Active research partnerships: 12 major institutions
  • Collaborative research funding: $22.6 million
  • Cross-industry technology transfer agreements: 7

Ethical Scientific Practice

Rigorous ethical standards in biotechnology research.

Ethical Compliance Metric 2024 Status
Regulatory Compliance Audits 100% passed
External Ethics Review Panels 3 independent panels

DCF model

Twist Bioscience Corporation (TWST) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.